From: Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
 |  | No. 66 | No. 377 | No. 1049 | |||
---|---|---|---|---|---|---|---|
Section | Gene name | CD133- | CD133+ | CD133- | CD133+ | CD133- | CD133+ |
A | CD90 | 1 | 15.6 ± 0.66 | 1 | 12.8 ± 0.94 | 1 | 13.5 ± 0.75 |
 | CD44 | 1 | 5.7 ± 0.48 | 1 | 2.5 ± 0.22 | 1 | 2.8 ± 0.19 |
 | CXCR4 | 1 | 337.8 ± 29.2 | 1 | 251.5 ± 22.1 | 1 | 264.9 ± 22.9 |
 | Nestin | 1 | 21.4 ± 1.25 | 1 | 23.2 ± 1.65 | 1 | 22.1 ± 1.54 |
 | MSI | 1 | 84 ± 7.6 | 1 | 75.4 ± 7.03 | 1 | 53.5 ± 6.2 |
 | MELK | 1 | 1351 ± 95.8 | 1 | 467.7 ± 40.5 | 1 | 514.6 ± 45.6 |
 | GLI-1 | 1 | 46 ± 3.8 | 1 | 43 ± 4.5 | 1 | 49 ± 5.9 |
 | PTCH | 1 | 16 ± 1.48 | 1 | 13.5 ± 0.85 | 1 | 14.3 ± 1.24 |
B | MGMT | 1 | 32.4 ± 2.5 | 1 | 34.7 ± 2.9 | 1 | 56.3 ± 4.2 |
 | BCRP1 | 1 | 6.5 ± 0.43 | 1 | 4.3 ± 0.25 | 1 | 4.8 ± 0.24 |
 | SIRT1 | 1 | 4.9 ± 0.34 | 1 | 4.2 ± 0.26 | 1 | 5.4 ± 0.29 |
 | FLIP | 1 | 294 ± 25.5 | 1 | 157.6 ± 14.2 | 1 | 145.6 ± 13.7 |
 | BCL-2 | 1 | 13.9 ± 0.95 | 1 | 4.9 ± 0.54 | 1 | 3.8 ± 0.54 |
 | BCL-XL | 1 | 5.6 ± 0.39 | 1 | 3.2 ± 0.16 | 1 | 2.5 ± 0.14 |
 | cIAP1 | 1 | 39.0 ± 3.5 | 1 | 4.3 ± 0.53 | 1 | 5.6 ± 0.65 |
 | cIAP2 | 1 | 3 ± 0.25 | 1 | 1.9 ± 0.12 | 1 | 1.7 ± 0.14 |
 | XIAP | 1 | 21.9 ± 2.2 | 1 | 9.7 ± 0.68 | 1 | 10.3 ± 0.91 |
 | NAIP | 1 | 12.1 ± 0.75 | 1 | 6.4 ± 0.43 | 1 | 4.5 ± 0.62 |
 | Survivin | 1 | 1.6 ± 0.08 | 1 | 2.3 ± 0.18 | 1 | 2.4 ± 0.18 |
 | BAX | 1 | 0.33 ± 0.03 | 1 | 0.49 ± 0.06 | 1 | 0.21 ± 0.05 |